NO20012152L - Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav - Google Patents

Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav

Info

Publication number
NO20012152L
NO20012152L NO20012152A NO20012152A NO20012152L NO 20012152 L NO20012152 L NO 20012152L NO 20012152 A NO20012152 A NO 20012152A NO 20012152 A NO20012152 A NO 20012152A NO 20012152 L NO20012152 L NO 20012152L
Authority
NO
Norway
Prior art keywords
cell proliferation
producing
same
inhibiting cell
compositions
Prior art date
Application number
NO20012152A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012152D0 (no
Inventor
Shirin Asina
Kanti Jain
Albert L Rubin
Barry Smith
Kurt Stenzel
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of NO20012152D0 publication Critical patent/NO20012152D0/no
Publication of NO20012152L publication Critical patent/NO20012152L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
NO20012152A 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav NO20012152L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/188,476 US6224912B1 (en) 1996-04-03 1998-11-09 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
PCT/US1999/026413 WO2000027207A1 (en) 1998-11-09 1999-11-09 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof

Publications (2)

Publication Number Publication Date
NO20012152D0 NO20012152D0 (no) 2001-05-02
NO20012152L true NO20012152L (no) 2001-07-05

Family

ID=22693322

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20012152A NO20012152L (no) 1998-11-09 2001-05-02 Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20101615A NO20101615L (no) 1998-11-09 2010-11-17 Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.

Country Status (19)

Country Link
US (4) US6224912B1 (de)
EP (1) EP1128731B1 (de)
JP (2) JP4294223B2 (de)
KR (3) KR20020013465A (de)
CN (1) CN1325271A (de)
AT (1) ATE446678T1 (de)
AU (1) AU769411B2 (de)
CA (1) CA2334483C (de)
DE (1) DE69941599D1 (de)
DK (1) DK1128731T3 (de)
EG (1) EG24212A (de)
ES (1) ES2335723T3 (de)
HK (1) HK1039439A1 (de)
IL (3) IL139704A0 (de)
NO (2) NO20012152L (de)
NZ (1) NZ511220A (de)
PT (1) PT1128731E (de)
RU (2) RU2268735C1 (de)
WO (1) WO2000027207A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39542E1 (en) * 1994-01-13 2007-04-03 The Rogosin Institute Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
RU2208636C2 (ru) * 1994-01-13 2003-07-20 Дзе Рогозин Институт Макрогранула с секреторными клетками, способ ее получения и способ лечения заболеваний, вызванных нарушением функционирования секреторных клеток
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US20050053586A1 (en) * 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
US20060121077A1 (en) * 2004-11-11 2006-06-08 Lawrence Gazda Method for treating patients with implants of islets which have been kept in long term, in vitro culture
PT1928249E (pt) * 2005-09-26 2012-05-25 Rogosin Inst Inc Macrocontas contendo células secretoras compreendendo agarose seakem gold e utilizações destas
KR101503079B1 (ko) 2007-06-08 2015-03-16 하마마츠 포토닉스 가부시키가이샤 분광기
EP2063239A4 (de) 2007-06-08 2013-12-25 Hamamatsu Photonics Kk Spektroskopisches modul
JP4891841B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
JP4891840B2 (ja) 2007-06-08 2012-03-07 浜松ホトニクス株式会社 分光モジュール
JP4887221B2 (ja) 2007-06-08 2012-02-29 浜松ホトニクス株式会社 分光モジュール
US8049887B2 (en) 2007-06-08 2011-11-01 Hamamatsu Photonics K.K. Spectroscopic module
KR20100017083A (ko) 2007-06-08 2010-02-16 하마마츠 포토닉스 가부시키가이샤 분광 모듈
US20090098055A1 (en) 2007-08-23 2009-04-16 Intrexon Corporation Methods and Compositions for Diagnosing Disease
US20090136465A1 (en) 2007-09-28 2009-05-28 Intrexon Corporation Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
WO2009110110A1 (ja) 2008-03-04 2009-09-11 浜松ホトニクス株式会社 分光モジュール
JP5205240B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュールの製造方法及び分光モジュール
JP2009300418A (ja) 2008-05-15 2009-12-24 Hamamatsu Photonics Kk 分光モジュール
JP5415060B2 (ja) 2008-05-15 2014-02-12 浜松ホトニクス株式会社 分光モジュール
JP5512961B2 (ja) 2008-05-15 2014-06-04 浜松ホトニクス株式会社 分光モジュール及びその製造方法
JP5207938B2 (ja) 2008-05-15 2013-06-12 浜松ホトニクス株式会社 分光モジュール及び分光モジュールの製造方法
JP5205241B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
JP5205238B2 (ja) 2008-05-15 2013-06-05 浜松ホトニクス株式会社 分光モジュール
EP2412800A1 (de) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Leberorganoid, Verwendungen davon und Kultivierungsverfahren zum Erhalten davon
US8572921B2 (en) * 2009-03-27 2013-11-05 Davinci Roofscapes, Llc One piece hip and ridge shingle
EP3228629A1 (de) * 2010-06-16 2017-10-11 Minerva Biotechnologies Corporation Neuprogrammierung von krebszellen
CN103052393B (zh) * 2010-08-12 2017-11-14 詹森生物科技公司 用胰腺内分泌前体细胞治疗糖尿病
HUE035164T2 (en) * 2010-11-23 2018-05-02 The Rogosin Inst Inc A method for isolating a cancer cell resistant to a chemotherapeutic agent that exhibits stem cell properties
AP2014007623A0 (en) 2012-01-31 2014-05-31 Rogosin Inst Improved method for manufacture of macrobeads
CN108780094B (zh) 2016-01-12 2022-09-13 生物蛋白有限公司 使用条件活性抗体的诊断方法
KR200485213Y1 (ko) 2016-11-02 2017-12-07 고수한 높이 조절이 가능한 조립식평상
JP7763450B2 (ja) * 2018-02-02 2025-11-04 ウェイク・フォレスト・ユニバーシティ・ヘルス・サイエンシーズ 免疫療法に関するオルガノイドならびにそれを調製および使用する方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865689A (en) 1972-11-09 1975-02-11 Hoffmann La Roche Method of producing carcinoembryonic antigens
US4285930A (en) 1977-12-08 1981-08-25 Likhite Vilas V Antigens comprising immunostimulant adjuvants and their use in immunotherapy
US4409331A (en) 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
DE3032931C2 (de) 1980-09-02 1982-07-29 Robert Bürkle GmbH & Co, 7290 Freudenstadt Verfahren und Anordnung zur Herstellung von Mehrschicht-Leiterplatten
SE441009B (sv) 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4798786A (en) 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
JPS5933223A (ja) 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
CA1196862A (en) 1983-06-01 1985-11-19 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4663286A (en) 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4680174A (en) 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
JPS6118721A (ja) 1984-07-06 1986-01-27 Kyowa Hakko Kogyo Co Ltd 新規抗腫瘍性物質
US4902295A (en) 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US4997443A (en) 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US5618715A (en) 1985-12-20 1997-04-08 Oncogen Limited Partnership Oncostatin M and novel compositions having anti-neoplastic activity
SE8604684L (sv) 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
JPS6463395A (en) 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
JPH0216994A (ja) 1988-07-05 1990-01-19 Nippon Mining Co Ltd 細胞増殖阻害因子及びその製造方法
US5053332A (en) 1989-07-24 1991-10-01 Cook Richard B Agarose beads, preferably incorporating biological materials
US5227298A (en) 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
SG47470A1 (en) 1991-04-25 1998-04-17 Univ Brown Res Found Implantable biocompatible immunoisolatory vehicle for delivery of a selected therapeutic products
US5800829A (en) 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
ZA939117B (en) * 1992-12-04 1994-08-05 Susanna Elizabeth Chalmers Pharmaceutical product
ES2178654T3 (es) 1993-08-12 2003-01-01 Neurotech Sa Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas.
RU2208636C2 (ru) * 1994-01-13 2003-07-20 Дзе Рогозин Институт Макрогранула с секреторными клетками, способ ее получения и способ лечения заболеваний, вызванных нарушением функционирования секреторных клеток
EP0769932B1 (de) 1994-07-08 1998-10-14 Baxter International Inc. Implantierte vorrichtung mit tumorzellen zur behandlung von krebs
PT914043E (pt) 1996-04-03 2004-02-27 Rogosin Inst Perolas de agarose-colagenio implantaveis contendo celulas que produzem um produto biologico difusivel e suas utilizacoes
US5888497A (en) * 1996-04-03 1999-03-30 The Rogosin Institute Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment

Also Published As

Publication number Publication date
WO2000027207A1 (en) 2000-05-18
HK1039439A1 (zh) 2002-04-26
IL177967A (en) 2010-12-30
US6818230B2 (en) 2004-11-16
IL139704A0 (en) 2002-02-10
ES2335723T3 (es) 2010-03-31
JP2002529060A (ja) 2002-09-10
AU1472600A (en) 2000-05-29
US20030143739A1 (en) 2003-07-31
CA2334483A1 (en) 2000-05-18
KR20050055797A (ko) 2005-06-13
CA2334483C (en) 2012-01-10
EP1128731B1 (de) 2009-10-28
DE69941599D1 (de) 2009-12-10
IL139704A (en) 2006-12-31
EP1128731A4 (de) 2003-06-04
EP1128731A1 (de) 2001-09-05
KR20020013465A (ko) 2002-02-20
ATE446678T1 (de) 2009-11-15
NO20012152D0 (no) 2001-05-02
AU769411B2 (en) 2004-01-29
PT1128731E (pt) 2010-02-02
WO2000027207A8 (en) 2000-09-21
US6808705B2 (en) 2004-10-26
KR20040075922A (ko) 2004-08-30
US6224912B1 (en) 2001-05-01
RU2268735C1 (ru) 2006-01-27
NO20101615L (no) 2001-07-05
IL177967A0 (en) 2006-12-31
US20030143281A1 (en) 2003-07-31
US20020168415A1 (en) 2002-11-14
NZ511220A (en) 2003-12-19
JP2005343899A (ja) 2005-12-15
RU2236855C2 (ru) 2004-09-27
CN1325271A (zh) 2001-12-05
US7041504B2 (en) 2006-05-09
EG24212A (en) 2008-10-28
RU2004115040A (ru) 2005-10-27
JP4294223B2 (ja) 2009-07-08
DK1128731T3 (da) 2010-01-25

Similar Documents

Publication Publication Date Title
NO20101615L (no) Materiale for hemming av proliferasjon av celler, og fremgangsmate til fremstilling av samme, og anvendelse derav.
CA2291222A1 (en) Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation
WO1998053618A3 (en) Enhanced cellular layout for cdma networks having six-sectored cells
CA2308177A1 (en) Intravascular stent and method for manufacturing an intravascular stent
WO1998007830A3 (en) COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
AU7585598A (en) Raf kinase inhibitors
AU1378499A (en) Methods for treating prostate tumors using radioactive compositions
AP2001002225A0 (en) 1-heterocycle substituted diarylamines.
NO975557D0 (no) Immortalisering og dismortalisering av celler
GR3019289T3 (en) Steroid sulphatase inhibitors
WO2002030465A3 (en) Compositions that inhibit proliferation of cancer cells
ATE347741T1 (de) Substratgestützte elektroden-elektrolyt-einheit
DK0880569T3 (da) Kompositioner til behandling af jord, fremgangsmåde til fremstilling deraf og anvendelse deraf
AU1802100A (en) Floating pesticide compositions for paddy fields, method for the utilization thereof and process for producing the same
WO2003024405A3 (en) Methods and compositions for inhibiting the proliferation of prostate cancer cells
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
IT1194148B (it) Enzimi fibrinolitici,procedimenti per la loro produzione e composizioni farmaceutiche che li contengono
IN187760B (de)
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
WO2000040752A3 (en) Cancer associated genes and their products
EP1328279A4 (de) Zusammensetzungen aus lignin und verfahren zu ihrer herstellung und verwendung
ES1028395U (es) Teleportero mejorado
MXPA00006072A (es) Metodos y composiciones para inhibir el crecimiento de celulas tumorales.
EP1518930A3 (de) Verfahren und Zusammensetzung zur Hemmung des Wachsdums von neoplastischen Zellen
UA29212A (uk) Спосіб лікування раку тіла матки iii-iv стадії

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application